India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What kind of disease is polio, why should you get vaccinated? A modified form of polio virus was found when a sample of sewage collected near the Tukucha-Bagamati confluence of Kathmandu was tested. After the detection of polio bacteria, a special vaccination campaign against polio is being conducted in Kathmandu, Lalitpur and Bhaktapur. A modified form of polio, type '3' bacteria has been found. Child Health and Immunization Division Head under the Family Welfare Division should be given mandatory polio vaccination for children under five years of age. Abhiyaan Gautam explains. Why is polio vaccination important? How effective is the vaccine against polio? Dr. etc. Edited part of online journalist Sumitra Luitel's conversation with Gautam: What disease is polio? Polio is a disease caused by the virus. It spreads mainly through person-to-person contact. It is spread by consuming food or drinks containing feces and urine of an infected person. Polio mainly affects children ...